-
Something wrong with this record ?
No effect of riluzole and memantine on learning deficit following quinpirole sensitization - An animal model of obsessive-compulsive disorder
M. Janikova, H. Brozka, D. Radostova, J. Svoboda, A. Stuchlik,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Dopamine Agonists pharmacology MeSH
- Excitatory Amino Acid Antagonists pharmacology MeSH
- Quinpirole pharmacology MeSH
- Behavior, Animal drug effects MeSH
- Cognition drug effects MeSH
- Rats MeSH
- Memantine pharmacology MeSH
- Disease Models, Animal MeSH
- Obsessive-Compulsive Disorder * MeSH
- Motor Activity drug effects MeSH
- Rats, Long-Evans MeSH
- Riluzole pharmacology MeSH
- Learning drug effects MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
RATIONALE: Chronic quinpirole (QNP) sensitization is an established animal model relevant to obsessive-compulsive disorder (OCD) that has been previously shown to induce several OCD-like behavioral patterns, such as compulsive-like checking and increased locomotion. OBJECTIVES: In current study we explored the effect of antiglutamatergic drugs, memantine and riluzole, on cognitive and behavioral performance of QNP sensitized rats. METHODS: During habituation phase, the rats (N = 56) were injected with QNP (0.25 mg/kg) or saline solution (every other day up to 10 injections) and placed into rotating arena without foot shocks for 50-min exploration. Active place avoidance task in rotating arena with unmarked to-be-avoided shock sector was used during acquisition phase. Rats were injected with memantine (1 mg/kg or 5 mg/kg), riluzole (1 mg/kg or 5 mg/kg) or saline solution 30 min before the trial and with QNP (0.25 mg/kg) or saline right before they were placed inside the rotating arena with 60° unmarked shock sector. Locomotion and number of entrances into the shock sector were recorded. RESULTS: QNP sensitization led to a robust deficit in place learning. However, neither memantine nor riluzole did reverse or alleviate the deficit induced by QNP. Contrarily, memantine significantly aggravated QNP induced deficit. CONCLUSIONS: The exacerbation of cognitive deficit following antiglutamatergic agents could be mediated by decreased glutamate concentration in nucleus accumbens and decreased hippocampal activation in the QNP sensitization model.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023944
- 003
- CZ-PrNML
- 005
- 20201214131850.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.physbeh.2019.01.013 $2 doi
- 035 __
- $a (PubMed)30826389
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Janikova, Martina $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Electronic address: martina.janikova@fgu.cas.cz.
- 245 10
- $a No effect of riluzole and memantine on learning deficit following quinpirole sensitization - An animal model of obsessive-compulsive disorder / $c M. Janikova, H. Brozka, D. Radostova, J. Svoboda, A. Stuchlik,
- 520 9_
- $a RATIONALE: Chronic quinpirole (QNP) sensitization is an established animal model relevant to obsessive-compulsive disorder (OCD) that has been previously shown to induce several OCD-like behavioral patterns, such as compulsive-like checking and increased locomotion. OBJECTIVES: In current study we explored the effect of antiglutamatergic drugs, memantine and riluzole, on cognitive and behavioral performance of QNP sensitized rats. METHODS: During habituation phase, the rats (N = 56) were injected with QNP (0.25 mg/kg) or saline solution (every other day up to 10 injections) and placed into rotating arena without foot shocks for 50-min exploration. Active place avoidance task in rotating arena with unmarked to-be-avoided shock sector was used during acquisition phase. Rats were injected with memantine (1 mg/kg or 5 mg/kg), riluzole (1 mg/kg or 5 mg/kg) or saline solution 30 min before the trial and with QNP (0.25 mg/kg) or saline right before they were placed inside the rotating arena with 60° unmarked shock sector. Locomotion and number of entrances into the shock sector were recorded. RESULTS: QNP sensitization led to a robust deficit in place learning. However, neither memantine nor riluzole did reverse or alleviate the deficit induced by QNP. Contrarily, memantine significantly aggravated QNP induced deficit. CONCLUSIONS: The exacerbation of cognitive deficit following antiglutamatergic agents could be mediated by decreased glutamate concentration in nucleus accumbens and decreased hippocampal activation in the QNP sensitization model.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a chování zvířat $x účinky léků $7 D001522
- 650 _2
- $a kognice $x účinky léků $7 D003071
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a agonisté dopaminu $x farmakologie $7 D018491
- 650 _2
- $a antagonisté excitačních aminokyselin $x farmakologie $7 D018691
- 650 _2
- $a učení $x účinky léků $7 D007858
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a memantin $x farmakologie $7 D008559
- 650 _2
- $a pohybová aktivita $x účinky léků $7 D009043
- 650 12
- $a obsedantně kompulzivní porucha $7 D009771
- 650 _2
- $a chinpyrol $x farmakologie $7 D019257
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Long-Evans $7 D020318
- 650 _2
- $a riluzol $x farmakologie $7 D019782
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Brozka, Hana $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Radostova, Dominika $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Svoboda, Jan $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Stuchlik, Ales $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Electronic address: ales.stuchlik@fgu.cas.cz.
- 773 0_
- $w MED00003826 $t Physiology & behavior $x 1873-507X $g Roč. 204, č. - (2019), s. 241-247
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30826389 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214131850 $b ABA008
- 999 __
- $a ok $b bmc $g 1596263 $s 1114620
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 204 $c - $d 241-247 $e 20190228 $i 1873-507X $m Physiology & behavior $n Physiol Behav $x MED00003826
- LZP __
- $a Pubmed-20201125